Clinical trial
Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
NCT01476449 is registered in ClinicalTrials.gov with Retina Vitreous Associates of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monthly Ranibizumab Versus Treat and Extend Ranibizumab for Diabetic Macular Edema
- Lead sponsor
- Retina Vitreous Associates of Florida
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- September 30, 2016
- Enrollment
- 20 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.